Cite
5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases
MLA
Marc Sapoval, et al. “5-FU or Mitomycin C Hepatic Arterial Infusion after Failure of Arterial Oxaliplatin in Patients with Colorectal Cancer Unresectable Liver Metastases.” Clinics and Research in Hepatology and Gastroenterology, vol. 42, June 2018, pp. 255–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3f19f534f49a529c83f17881c89d0c1c&authtype=sso&custid=ns315887.
APA
Marc Sapoval, Rapahel Hampig Kourie, Bruno Landi, Gregory Amouyal, Anne-Laure Pointet, Olivier Pellerin, Céline Lepère, Julien Taieb, Yosra Zaimi, Simon Pernot, & Guillaume Velut. (2018). 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases. Clinics and Research in Hepatology and Gastroenterology, 42, 255–260.
Chicago
Marc Sapoval, Rapahel Hampig Kourie, Bruno Landi, Gregory Amouyal, Anne-Laure Pointet, Olivier Pellerin, Céline Lepère, et al. 2018. “5-FU or Mitomycin C Hepatic Arterial Infusion after Failure of Arterial Oxaliplatin in Patients with Colorectal Cancer Unresectable Liver Metastases.” Clinics and Research in Hepatology and Gastroenterology 42 (June): 255–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3f19f534f49a529c83f17881c89d0c1c&authtype=sso&custid=ns315887.